TY - JOUR
T1 - Vitamin D deficiency predicts prostate biopsy outcomes
AU - Murphy, Adam B.
AU - Nyame, Yaw
AU - Martin, Iman K.
AU - Catalona, William J.
AU - Hollowell, Courtney M P
AU - Nadler, Robert B.
AU - Kozlowski, James M.
AU - Perry, Kent T.
AU - Kajdacsy-Balla, Andre
AU - Kittles, Rick
PY - 2014/5/1
Y1 - 2014/5/1
N2 - Purpose: The association between vitamin D and prostate biopsy outcomes has not been evaluated. We examine serum vitamin D levels with prostate biopsy results in men with an abnormal prostate-specific antigen and/or digital rectal examination. Experimental Design: Serum 25-hydroxyvitamin D (25-OH D) was obtained from 667 men, ages 40 to 79 years, prospectively enrolled from Chicago urology clinics undergoing first prostate biopsy. Logistic regression was used to evaluate the associations between 25-OH D status and incident prostate cancer, Gleason score, and tumor stage. Results: Among European American (EA) men, there was an association of 25-OH D
AB - Purpose: The association between vitamin D and prostate biopsy outcomes has not been evaluated. We examine serum vitamin D levels with prostate biopsy results in men with an abnormal prostate-specific antigen and/or digital rectal examination. Experimental Design: Serum 25-hydroxyvitamin D (25-OH D) was obtained from 667 men, ages 40 to 79 years, prospectively enrolled from Chicago urology clinics undergoing first prostate biopsy. Logistic regression was used to evaluate the associations between 25-OH D status and incident prostate cancer, Gleason score, and tumor stage. Results: Among European American (EA) men, there was an association of 25-OH D
UR - http://www.scopus.com/inward/record.url?scp=84899765304&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84899765304&partnerID=8YFLogxK
U2 - 10.1158/1078-0432.CCR-13-3085
DO - 10.1158/1078-0432.CCR-13-3085
M3 - Article
C2 - 24789033
AN - SCOPUS:84899765304
SN - 1078-0432
VL - 20
SP - 2289
EP - 2299
JO - Clinical Cancer Research
JF - Clinical Cancer Research
IS - 9
ER -
